GOLGA6L9 and Alzheimer disease: Although GOLGA6L9 is a novel locus never reported previously, variant rs2665103, the shared risk loci of AD and cognition-related phenotypes identified by conjFDR statistics, upregulates GOLGA6L9 expression in cerebellum, suggesting its potential biological role (β = 0.56, p = 7.4E-08).